Ocular Therapeutix, Inc financial data

Symbol
OCUL on Nasdaq
Industry
Pharmaceutical Preparations
Location
15 Crosby Drive, Bedford, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
I-THERAPEUTIX INC (to 7/2/2009)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.12K % +185%
Quick Ratio 7.79 % +19.8%
Debt-to-equity 66.2 % -86.5%
Return On Equity -62.6 % +83.7%
Return On Assets -37.6 % +42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 156M shares +96.4%
Common Stock, Shares, Outstanding 156M shares +96.4%
Entity Public Float 406M USD +42.9%
Common Stock, Value, Issued 16K USD +100%
Weighted Average Number of Shares Outstanding, Basic 166M shares +112%
Weighted Average Number of Shares Outstanding, Diluted 166M shares +112%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 61.1M USD +11.9%
Research and Development Expense 80.8M USD +41.5%
Selling and Marketing Expense 38.7M USD -9.29%
General and Administrative Expense 50.4M USD +47.4%
Costs and Expenses 176M USD +26.7%
Operating Income (Loss) -114M USD -36.2%
Nonoperating Income (Expense) -23.9M USD -256%
Net Income (Loss) Attributable to Parent -138M USD -52.5%
Earnings Per Share, Basic -1.11 USD/shares +5.13%
Earnings Per Share, Diluted -1.12 USD/shares +2.61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 460M USD +590%
Accounts Receivable, after Allowance for Credit Loss, Current 30.2M USD +10.7%
Inventory, Net 2.55M USD +15.6%
Assets, Current 499M USD +395%
Property, Plant and Equipment, Net 10.9M USD -15.1%
Operating Lease, Right-of-Use Asset 6.01M USD -17.2%
Assets 517M USD +322%
Accounts Payable, Current 3.69M USD +3.28%
Employee-related Liabilities, Current 8.44M USD +35.3%
Accrued Liabilities, Current 24.4M USD -0.98%
Contract with Customer, Liability, Current 269K USD -31.2%
Liabilities, Current 30M USD -7.37%
Contract with Customer, Liability, Noncurrent 14M USD -1.78%
Operating Lease, Liability, Noncurrent 6.1M USD -20.7%
Other Liabilities, Noncurrent 114K USD +9.62%
Liabilities 139M USD +16.7%
Retained Earnings (Accumulated Deficit) -806M USD -20.7%
Stockholders' Equity Attributable to Parent 378M USD +12135%
Liabilities and Equity 517M USD +322%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.9M USD -69.7%
Net Cash Provided by (Used in) Financing Activities 321M USD +411724%
Net Cash Provided by (Used in) Investing Activities -255K USD +92.5%
Common Stock, Shares Authorized 400M shares +100%
Common Stock, Shares, Issued 156M shares +96.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 287M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 461M USD +575%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13M USD +1750%
Deferred Tax Assets, Valuation Allowance 184M USD +11.7%
Deferred Tax Assets, Gross 195M USD +15.5%
Operating Lease, Liability 8.46M USD -17.6%
Payments to Acquire Property, Plant, and Equipment 255K USD -92.5%
Lessee, Operating Lease, Liability, to be Paid 10.7M USD -21.6%
Property, Plant and Equipment, Gross 32M USD +17.9%
Operating Lease, Liability, Current 1.66M USD -3.33%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.67M USD -4.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.5M USD -5.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -7.46%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.25M USD -33.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.71M USD +1.31%
Deferred Tax Assets, Operating Loss Carryforwards 121M USD +6.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.11M USD -22.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 920K USD +90.5%
Deferred Tax Assets, Net of Valuation Allowance 10.8M USD +174%
Share-based Payment Arrangement, Expense 28.1M USD +61%
Interest Expense 13.6M USD +91.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%